Adherence and discontinuation rates in patients on Tecfidera™ (dimethyl fumarate): Long-term Canadian experience from the Biogen ONE™ support program.
Saved in:
| Title: | Adherence and discontinuation rates in patients on Tecfidera™ (dimethyl fumarate): Long-term Canadian experience from the Biogen ONE™ support program. |
|---|---|
| Authors: | Thompson MT; Biogen Canada Inc., 3250 Bloor Street West, East Tower, Suite 1200, Toronto, ON M8X 2X9, Canada., Virginia D; University of British Columbia, 2211 Wesbrook Mall, Vancouver, BC, Canada., Nick B; Biogen, 225 Binney Street, Cambridge, MA, USA., Melissa G; Biogen Canada Inc., 3250 Bloor Street West, East Tower, Suite 1200, Toronto, ON M8X 2X9, Canada., Engineer N; Biogen Canada Inc., 3250 Bloor Street West, East Tower, Suite 1200, Toronto, ON M8X 2X9, Canada., Shen C; Biogen, 225 Binney Street, Cambridge, MA, USA., Reedie S; Biogen Canada Inc., 3250 Bloor Street West, East Tower, Suite 1200, Toronto, ON M8X 2X9, Canada. Electronic address: scott.reedie@biogen.com. |
| Source: | Multiple sclerosis and related disorders [Mult Scler Relat Disord] 2022 Nov; Vol. 67, pp. 104080. Date of Electronic Publication: 2022 Jul 28. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier B. V Country of Publication: Netherlands NLM ID: 101580247 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2211-0356 (Electronic) Linking ISSN: 22110348 NLM ISO Abbreviation: Mult Scler Relat Disord Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
